MelioLabs Inc.

Milpitas, CA · Founded 2018 · CIK 0001915402 · Medtech · Private

MeltSeq, a molecular diagnostic platform for rapid pathogen identification from small-volume blood samples, specifically designed to detect Treponema pallidum (syphilis) and differentiate strains in n

Grants
$600K
2 awards
Sector median: 1
Raised
$4.0M
2 Form D · Jul 2024
27 months since last filing
Contracts
—
No federal contracts on record
Patents
9
3 granted · 6 pending
Sector median: 2

Capital Timeline

Federal above the line · equity below · node area scaled to amount
Capital and federal award history
DateEventSourceAmount
Federal grantDepartment of Health and Human Services · Phase I · Rapid and broad pathogen profiling system for infection in newborn$299,734
Federal grantDepartment of Health and Human Services · Phase I · A rapid test for congenital syphilis screening$299,891
Private capital raisedForm D · SEC$4,000,000
Federal grant · SBIR/STTRForm D · SEC

Peer position

Medtech · 4531 companies · ranked on federal contract value
Medtech companies ranked by federal contract value
#CompanyContractsDisclosed equity
823Carestream Dental Alpha Ltd—$4.9M
824PIROUETTE PHARMA INC.—$14M
825Ictero Medical, Inc.—$2.5M
826MelioLabs Inc.—$4.0M
827Tetrous, Inc.—$2.2M
828Sonex Health, Inc.—$22M
829Virtech Bio, Inc.—$500K

Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.

Founders & Team

From Form D filings · 1 related persons
  • Mridu SinhaDirector · Executive Officer

Patents

USPTO · 3 granted of 9

Regulatory activity · Medtech

Sector-level, not company-level

Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.